You're Eating Right and Still Gaining Weight. Here's Why.

Your leptin receptor is the cell phone your fat cells use to call your brain and say “we’re full.” When leptin binds to the LEPR receptor in your hypothalamus, it tells your brain to stop feeling hungry and to increase energy expenditure. This is how your body knows to stop eating. It’s the master satiety signal.

When the LEPR gene carries variants that impair receptor function, your brain never fully receives the message that you’re full, even when your body has plenty of stored energy. Studies show that roughly 20 to 30 percent of people carry LEPR variants that reduce receptor sensitivity. The result is that you feel perpetually hungry and your brain believes you’re in a state of caloric deprivation even when you’re eating normally or more than enough. You’re not lacking willpower. Your brain is simply not receiving the hormonal signal that tells it to be satisfied.

This manifests as constant hunger, cravings that don’t respond to eating, difficulty recognizing fullness, and a tendency to overeat even when you intellectually know you should stop. People with LEPR variants often report that they can eat a full meal and feel hungry an hour later, or that they never feel satisfied no matter how much they eat. Portion control becomes nearly impossible because the biological signal that triggers satiety is broken.

The FTO gene controls appetite signaling in your brain’s hypothalamus. Specifically, it regulates the balance between hunger-promoting signals (like NPY) and satiety-promoting signals (like POMC). When FTO is working normally, it helps your brain assess energy status and adjust hunger appropriately.

The FTO rs9939609 A allele, carried by roughly 45 percent of people with European ancestry, impairs this appetite control system. People with the A allele have weaker satiety signaling and show a strong genetic preference for high-fat, calorie-dense foods. This isn’t a taste preference you can overcome with willpower. It’s a biological drive encoded in your brain’s appetite circuits. Studies show that carriers of the A allele consume roughly 200 to 300 more calories per day simply because their appetite regulation is less precise.

You experience this as a strong pull toward fatty foods, difficulty with portion control especially around high-fat meals, and a tendency to graze or snack even when you’re not hungry. The hunger feels real and urgent because it is real; your appetite centers are literally sending stronger signals. You might notice that salads and lean proteins don’t satisfy you the way high-fat foods do, and that you can eat a large amount of low-fat food without feeling full.

PPARG is a master regulator of fat cell development and function. It controls how readily your body converts excess calories into stored fat and how efficiently those fat cells can release stored energy. When PPARG works normally, it helps balance fat storage with fat mobilization based on energy needs.

The PPARG Pro12 variant, present in roughly 25 percent of the population, promotes efficient fat storage and shifts your metabolism toward accumulation rather than mobilization. People carrying Pro12 have fat cells that preferentially store energy and show reduced responsiveness to fat-mobilizing signals during exercise and fasting. This means your body is genetically wired to pack away calories efficiently but struggles to release them when you need energy. Low-fat diets make this problem worse because they reduce the very nutrient (fat) that might otherwise satisfy the drive to store.

You might notice that weight comes on easily, especially during periods of stress or slight overeating, and that it’s stubborn to lose even with calorie deficit. Exercise might not produce the expected fat loss because your fat cells aren’t responding optimally to the mobilization signals. You may also find that carb-heavy diets trigger more weight gain than high-fat diets, even when calories are equal.

Estrogen receptors are the cellular locks that allow estrogen to exert its effects. ESR1 variants determine how sensitive your cells are to estrogen signaling. This affects fat distribution, appetite regulation, insulin sensitivity, and how your body stores energy. When estrogen signaling works normally, it helps regulate body weight and metabolic function, particularly in women.

The ESR1 PvuII and XbaI variants affect estrogen receptor expression and signaling efficiency. Roughly 40 percent of people carry variants that reduce estrogen receptor sensitivity. With reduced receptor sensitivity, your cells don’t respond optimally to estrogen, which impairs metabolic regulation, shifts fat storage toward the abdominal area, and can disrupt appetite control. This is why hormonal weight gain often appears after perimenopause or in response to hormonal changes. Your body needs more estrogen signal to achieve the same metabolic effect.

You might notice that weight accumulates around your abdomen and sides rather than hips and thighs, that your weight fluctuates with your menstrual cycle, that perimenopause triggered sudden weight gain despite no change in eating or exercise, or that you have difficulty losing weight specifically during the luteal phase of your cycle when estrogen drops.

COMT breaks down catecholamines (epinephrine and norepinephrine), the stress hormones that mobilize energy and prepare your body for action. When COMT works normally, you clear these hormones efficiently and return to a calm, parasympathetic state. This efficient clearance helps your metabolism reset and prevents chronic stress hormone elevation.

The COMT Val158Met slow-metabolizer variant, present in roughly 25 percent of people with European ancestry, impairs COMT enzyme activity by 25 to 40 percent. Slow COMT variants mean you clear stress hormones slowly, keeping your nervous system activated longer after stress and making your body interpret normal life demands as continuous threat. Chronic stress hormone elevation suppresses thyroid function, impairs fat mobilization, increases cortisol (which promotes abdominal fat storage), and disrupts hunger-satiety signaling. Your metabolic rate drops and your body shifts toward energy conservation and fat storage.

You likely notice that stress triggers weight gain even when you’re eating normally, that you’re prone to anxiety or overwhelm, that you have trouble recovering from stressful periods, that stimulants like caffeine make you feel more anxious, and that your weight becomes harder to manage during stressful life phases. You might also have a tendency toward perfectionism or difficulty letting go of perceived threats.

MTHFR controls methylation, a fundamental cellular process that regulates gene expression, hormone metabolism, neurotransmitter synthesis, and fat metabolism. Methylation is the chemical switch that turns genes on and off. When MTHFR works normally, your cells have plenty of methyl groups available to run these critical processes.

The MTHFR C677T variant, present in roughly 40 percent of people with European ancestry, reduces enzyme efficiency by 35 to 70 percent. This impairs methylation-dependent fat metabolism, increases homocysteine (which impairs metabolic function), and reduces your capacity to produce SAM-e, a critical molecule for metabolic regulation. As a result, your cells have reduced capacity to mobilize stored fat, regulate leptin sensitivity, and convert thyroid hormone into its active form. You’re literally running short on the chemical fuel needed for normal metabolism.

You might notice that you struggle with brain fog and fatigue in addition to weight gain, that your weight is coupled with elevated homocysteine, that you feel better when you include folate-rich foods, that B vitamins seem to help more than other supplements, or that your weight fluctuates with your stress levels (stress depletes methylation capacity).